Status:
COMPLETED
Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C
Chronic Hepatitis C
Eligibility:
All Genders
Brief Summary
The objective of this study is to assess the impact of participant care and support on treatment adherence. PegIntron pen and Rebetol will be administered to participants with Hepatitis C Virus (HCV) ...
Eligibility Criteria
Inclusion
- Participants with chronic hepatitis C.
- Those participating in patient assistance programs during therapy for hepatitis C.
Exclusion
- Participants who have previously been treatment for hepatitis C (non-naïve)
- Other exclusion criteria as described in local Summary of Product Characteristics (SPC).
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
746 Patients enrolled
Trial Details
Trial ID
NCT00704964
Start Date
May 1 2005
End Date
October 1 2009
Last Update
October 6 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.